Clinical Pharmacology of Proton Pump Inhibitors
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 63 (24) , 2739-2754
- https://doi.org/10.2165/00003495-200363240-00004
Abstract
Proton pump inhibitors (PPIs) [omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole] are widely utilised for the treatment of gastro-oesophageal reflux disease, as well as other...Keywords
This publication has 87 references indexed in Scilit:
- EsomeprazoleDrugs, 2002
- Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trialsClinical Therapeutics, 2001
- Drug Interaction Studies with Esomeprazole, the (S)-Isomer of OmeprazoleClinical Pharmacokinetics, 2001
- Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of OmeprazoleClinical Pharmacokinetics, 2001
- ENDOSCOPY-NEGATIVE GASTROESOPHAGEAL REFLUX DISEASE: The Hypersensitive EsophagusGastroenterology Clinics of North America, 1999
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- RabeprazoleDrugs, 1998
- Proton Pump InhibitorsDrugs, 1998
- Clinical Pharmacokinetics of LansoprazoleClinical Pharmacokinetics, 1995
- The role and limitations of H2‐receptor antagonist in the treatment of gastro‐oesophageal refrux diseaseAlimentary Pharmacology & Therapeutics, 1995